Navigation Links
John Theurer Cancer Center offers breakthrough radiation measurement technology
Date:5/17/2010

HACKENSACK, N.J. (May 17, 2010) John Theurer Cancer Center at Hackensack University Medical Center announced today that it is one of two cancer centers in the tri-state area currently implanting a wireless radiation sensor, known as DVS (Dose Verification System). John Theurer Cancer Center radiation oncologists can now receive data immediately post- treatment on the precise amount of radiation being delivered to tumors and surrounding tissue for prostate cancer treatments.

"Traditional radiation therapies rely on knowing the exact location of the tumor, but provide no guidance on quantifying the actual dose being delivered to the tumor," said Glen Gejerman, M.D., Co-Chief, Urologic Oncology and Director, Radiation Oncology, John Theurer Cancer Center. "With this implantable device, we can now offer critical same day radiation dose adjustments."

The DVS sensorsjust 2.1mm in diameter and 20mm longare implanted during a minimally invasive procedure and gather data on the precise amount of radiation being delivered to the tumor. Wireless technology transmits the information to a hand-held monitor and the amount of radiation absorbed is read at the end of each of the daily treatments, enabling doctors to verify that the patient is receiving the prescribed dose.

Deviations in dose delivered to the tumor, or radiation accidentally administered to normal tissue, can have a profound impact on long-term survival rates and quality of life for patients treated with radiation therapy. Accurate delivery of the appropriate dose of radiation is critical to tumor control and cure rate. A long-term clinical study of nearly 230 prostate cancer patients demonstrated statistical significance between dose and benefit, highlighting the importance of measuring the amount of dose delivered. 1

This is part of John Theurer Cancer Center's ongoing dedication to improving radiation oncology safety and precision through research and adopting the lates
'/>"/>

Contact: Jaymie DeGaetano
jaymie.degaetano@widmeyer.com
646-213-7243
John Theurer Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. John Theurer Cancer Center hosts hematologic malignancies program for physicians and patients
2. Researchers at the John Theurer Cancer Center Present Cutting-Edge Research Results at this Years American Society of Hematology Annual Meeting
3. Motorcycle Cancer Risk and ELF EMF Radiation Invasion of Gastrointestinal Melatonin
4. Clue to switch of bladder cancer from locally contained to invasive found by Jefferson scientists
5. 5th Annual Brittiana 'Smile For Life' 5k run/walk - Helping Children Survive Cancer One Smile at a Time
6. Relax for Hope May 23 - a Spa Day Fundraiser for the American Cancer Soiety's Relay for Life in Lincoln City, Oregon.
7. CIGNA and Cancer Treatment Centers of America Reach New Agreement
8. Can Celebrex prevent cancer-causing colon polyps?
9. Study identifies 1 of the mechanisms behind breast cancer metastasis
10. NYU College of Dentistry, Penn State develop new model for investigating tobacco/oral cancer link
11. New hope for better treatment for a rising cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2014)... July 26, 2014 The European security ... at $1290 million in 2014, and it is expected ... of 6.16%. The report incorporates the factors that influence ... of growth rates and projected total expenditure. The report ... global markets. Apart from the general overview of the ...
(Date:7/26/2014)... gas chromatography reagents report defines and segments the concerned market ... chromatography reagents market in Europe is valued at $ 314.8 ... $445.5 million by 2018, at a CAGR of 8.6 %, ... the European gas chromatography reagents market, to get an idea ... glimpse of the segmentation of gas chromatography reagents market in ...
(Date:7/26/2014)... July 26, 2014 (HealthDay News) -- Pools can provide ... make themselves sick if they swallow too much chlorinated ... it,s common for little ones to get water in ... from a pool, despite warnings from their parents. ... harmless, it,s important for parents to realize that ingesting ...
(Date:7/26/2014)... Dallas,Texas (PRWEB) July 26, 2014 “BRIC ... on the BRIC Sinuscopes market. The report provides value, ... average prices (in US dollars) within market segments – ... shares and distribution shares data for each of these ... market participants, pipeline products, and news and deals related ...
(Date:7/26/2014)... Everett, WA (PRWEB) July 26, 2014 “Healthy ... important in keeping those pearly whites shining,” says Community Health ... Your Teeth Healthy ." , They believe that an integration ... keep people healthy and well. Because of this, they encourage ... but also with dentist . , “Children and adults ...
Breaking Medicine News(10 mins):Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 4Health News:Europe Security and Surveillance Radar Market is Expected to Reach $1800 million in 2019 - New Report by MicroMarket Monitor 5Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 5Health News:Don't Let Kids Drink Pool Water 2Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 2Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 3Health News:Sinuscopes Market in BRIC (Brazil, Russia, India & China) Forecast to 2020 Report Available at MarketOptimizer.org 4Health News:Common Dental Care Questions Answered by Community Health Center of Snohomish County in Recent Article 2
... Pa., Nov. 24 WPCS International,Incorporated (Nasdaq: ... services for,specialty communication systems and wireless infrastructure, has ... $9 million in,new contracts. The contracts include projects ... Office of Emergency Management, YMCA, Group,Health Tacoma, UPS, ...
... ARAY ), a global leader in the field of radiosurgery, ... 20th Annual Piper Jaffray,Health Care Conference in New York City, ... PST). , A live ... relations page of the Company,s Web site at http://www.accuray.com ...
... 24 According to a new survey released,today, the vast majority ... percent -- are not taking the most basic steps of determining ... test if they are at,risk or taking the appropriate actions as ... baseline among Americans on their level of awareness and,knowledge regarding type ...
... Fight Against AIDS with their "Love for Life" Limited Edition ... 24 ALDO, a global fashion footwear and accessories ... program of the global health organization Population Services International, continues ... bracelets. ALDO has given more than $10 million ...
... of Drugs with Broad Potential to Treat Life-Threatening Viral Infections-- ... Agent Bavituximab and Equivalent Antibodies Cured Lethal Viral Infections in ... Confirms PS is a ,Druggable, Target Common to a Number ... TUSTIN, Calif., Nov. 24 Peregrine Pharmaceuticals, Inc. (Nasdaq: ...
... Cepheid,(Nasdaq: CPHD ) today announced that ... its Xpert(TM) MRSA/SA Skin and Soft Tissue (SSTI) ... (MRSA) and,Staphylococcus aureus (SA, typically Methicillin-sensitive) in skin ... MRSA/SA SSTI test is expected to,empower Canadian physicians ...
Cached Medicine News:Health News:WPCS Announces $9 Million in New Contracts 2Health News:Accuray Incorporated to Present at 20th Annual Piper Jaffray Health Care Conference 2Health News:New Survey Shows Majority of Americans Need to Take Proper Steps to Manage Diabetes Risk 2Health News:New Survey Shows Majority of Americans Need to Take Proper Steps to Manage Diabetes Risk 3Health News:New Survey Shows Majority of Americans Need to Take Proper Steps to Manage Diabetes Risk 4Health News:ALDO Supports World AIDS Day by Donating 100% of Proceeds for Newest 'ALDO Fights Aids' Product 2Health News:ALDO Supports World AIDS Day by Donating 100% of Proceeds for Newest 'ALDO Fights Aids' Product 3Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 2Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 3Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 4Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 5Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 6Health News:Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections 2Health News:Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections 3Health News:Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections 4
(Date:7/24/2014)... 24, 2014  Restore Health, a leading personalized ... announced that it is now offering pharmacogenetics testing ... individual based upon their particular genetic makeup. Comprehensive ... interaction between a patient,s genetics and their entire ... to provide this new service to healthcare providers ...
(Date:7/24/2014)... , Germany , and ... -- , Exclusive global license ... for SF3B1 mutations, including next-generation sequencing (NGS) gene panels, ... to be targeted by new test, indicate favorable prognosis ... syndromes  QIAGEN sees potential for developing companion ...
(Date:7/24/2014)... CITY, Calif., July 24, 2014  Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis systems, today reported financial results for ... First quarter overview: , Revenues of $47.5 ... , Diluted EPS of $0.21, up 50% over last ... Medical market revenues of $7.2 million, up 20% over ...
Breaking Medicine Technology:Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11
... Intercept Pharmaceuticals, Inc., has announced that its first-in-class farnesoid ... endpoint of improved insulin sensitization in a 6 week ... patients with nonalcoholic fatty liver disease (NAFLD). , By ... that a single oral daily dose of INT-747 statistically ...
... , ST. PAUL, Minn., Oct. 1 Algos Therapeutics ... today announces the selection of Dr. Ganesh Iyer as ... his new responsibilities immediately. , "We were incredibly fortunate ... Dr. Iyer to lead Algos," stated Gary Smaby, Algos ...
Cached Medicine Technology:Intercept Pharmaceuticals' FXR Agonist INT-747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease 2Algos Attracts CRO Veteran Dr. Ganesh Iyer as its New CEO 2
Stainless steel bone clamp....
Reduction Forceps with Points for precise reduction of bone fragments with minimal soft tissue contact....
Designed for proximal femoral elevation in total hip replacement or in other surgery with a similar need for bone manipulation....
Straight double action bone cutting rongeur....
Medicine Products: